PAB Price sensitive 23 Sep 2026, 8:57 AM

First Participants Dosed in RLS-2202 Phase 1A Clinical Trial

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.